These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 6397984)

  • 61. Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
    Polanski M; Karnovsky ML
    J Neuroimmunol; 1992 Mar; 37(1-2):149-60. PubMed ID: 1532180
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of ketanserin on 5-hydroxytryptamine-induced cerebrovascular spasm in the cat.
    Vällfors B; Dahlström A; Boström S; Ahlman H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S60-3. PubMed ID: 2412061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery.
    Tadipatri S; van Heuven-Nolsen D; Feniuk W; Saxena PR
    Br J Pharmacol; 1991 Dec; 104(4):887-94. PubMed ID: 1667289
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist.
    Hara H; Osakabe M; Kitajima A; Tamao Y; Kikumoto R
    Thromb Haemost; 1991 Apr; 65(4):415-20. PubMed ID: 2057925
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serotonin agonists and antagonists in experimental hypertension.
    Saxena PR; Bolt GR; Dhasmana KM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S12-8. PubMed ID: 2446059
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery.
    MacLennan SJ; Whittle MJ; McGrath JC
    Br J Pharmacol; 1989 Jul; 97(3):921-33. PubMed ID: 2503229
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH.
    De Clerck F; Xhonneux B; Tollenaere JP; Janssen PA
    Thromb Res; 1985 Dec; 40(5):581-96. PubMed ID: 2935970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction in rat isolated vena portae smooth muscle.
    Datté JY; Offoumou MA
    J Pharm Pharm Sci; 2004 Jan; 7(1):1-7. PubMed ID: 15144728
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307.
    Verdouw PD; Jennewein HM; Heiligers J; Duncker DJ; Saxena PR
    Eur J Pharmacol; 1984 Jul; 102(3-4):499-509. PubMed ID: 6548449
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Continuous inhibition of the platelet S2-serotonergic receptors during the long term administration of ketanserin.
    Vermylen J; Arnout J; Deckmyn H; Xhonneux B; De Clerck F
    Thromb Res; 1986 Jun; 42(5):721-3. PubMed ID: 2940729
    [No Abstract]   [Full Text] [Related]  

  • 73. 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation.
    Connor HE; Feniuk W; Humphrey PP
    Eur J Pharmacol; 1989 Feb; 161(1):91-4. PubMed ID: 2542039
    [TBL] [Abstract][Full Text] [Related]  

  • 74. AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats.
    Kihara H; Hirose K; Koganei H; Sasaki N; Yamamoto H; Kimura A; Nishimori T; Shoji M; Yoshimoto R
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):523-30. PubMed ID: 10774780
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Signalling pathways activated by 5-HT(1B)/5-HT(1D) receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells.
    Hinton JM; Hill P; Jeremy J; Garland C
    J Vasc Res; 2000; 37(6):457-68. PubMed ID: 11146399
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 5-hydroxytryptamine and precapillary vessels.
    Van Nueten JM
    Fed Proc; 1983 Feb; 42(2):223-7. PubMed ID: 6295823
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
    Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
    Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelets, endothelium and blood vessel wall.
    Vanhoutte PM
    Experientia; 1988 Feb; 44(2):105-9. PubMed ID: 3278917
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of ketanserin on serotonin-induced vascular responses in the isolated perfused rat lung.
    Le Roux MG; Syce JA
    Eur J Pharmacol; 1989 Oct; 169(2-3):269-73. PubMed ID: 2806384
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Allosteric properties of 5-HT2 receptors in tracheal smooth muscle.
    Lemoine H; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):91-7. PubMed ID: 2944004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.